153 related articles for article (PubMed ID: 12084892)
21. Subcutaneous immunoglobulin for maintenance treatment in chronic inflammatory demyelinating polyneuropathy (The PATH Study): study protocol for a randomized controlled trial.
van Schaik IN; van Geloven N; Bril V; Hartung HP; Lewis RA; Sobue G; Lawo JP; Mielke O; Cornblath DR; Merkies IS;
Trials; 2016 Jul; 17(1):345. PubMed ID: 27455854
[TBL] [Abstract][Full Text] [Related]
22. Blink R1 latency utility in diagnosis and treatment assessment of polyradiculoneuropathy-organomegaly-endocrinopathy-monoclonal protein-skin changes and chronic inflammatory demyelinating polyradiculoneuropathy.
Wang W; Litchy WJ; Mauermann ML; Dyck PJB; Dispenzieri A; Mandrekar J; Dyck PJ; Klein CJ
Muscle Nerve; 2018 Jan; 57(1):E8-E13. PubMed ID: 28646568
[TBL] [Abstract][Full Text] [Related]
23. Treatment of chronic inflammatory demyelinating polyneuropathy with pulsed oral steroids.
Muley SA; Kelkar P; Parry GJ
Arch Neurol; 2008 Nov; 65(11):1460-4. PubMed ID: 19001164
[TBL] [Abstract][Full Text] [Related]
24. Autologous haematopoietic stem cell transplantation: a viable treatment option for CIDP.
Press R; Askmark H; Svenningsson A; Andersen O; Axelson HW; Strömberg U; Wahlin A; Isaksson C; Johansson JE; Hägglund H
J Neurol Neurosurg Psychiatry; 2014 Jun; 85(6):618-24. PubMed ID: 24262917
[TBL] [Abstract][Full Text] [Related]
25. Intractable chronic inflammatory demyelinating polyneuropathy treated successfully with ciclosporin.
Odaka M; Tatsumoto M; Susuki K; Hirata K; Yuki N
J Neurol Neurosurg Psychiatry; 2005 Aug; 76(8):1115-20. PubMed ID: 16024890
[TBL] [Abstract][Full Text] [Related]
26. Treatment of chronic inflammatory demyelinating polyneuropathy with high-dose intermittent intravenous methylprednisolone.
Lopate G; Pestronk A; Al-Lozi M
Arch Neurol; 2005 Feb; 62(2):249-54. PubMed ID: 15710853
[TBL] [Abstract][Full Text] [Related]
27. Ultrasound aspects in therapy-naive CIDP compared to long-term treated CIDP.
Grimm A; Vittore D; Schubert V; Rasenack M; Décard BF; Heiling B; Hammer N; Axer H
J Neurol; 2016 Jun; 263(6):1074-82. PubMed ID: 27017343
[TBL] [Abstract][Full Text] [Related]
28. Evaluation of patients with refractory chronic inflammatory demyelinating polyneuropathy.
Kaplan A; Brannagan TH
Muscle Nerve; 2017 Apr; 55(4):476-482. PubMed ID: 27463215
[TBL] [Abstract][Full Text] [Related]
29. Investigations and treatment of chronic inflammatory demyelinating polyradiculoneuropathy and other inflammatory demyelinating polyneuropathies.
Tracy JA; Dyck PJ
Curr Opin Neurol; 2010 Jun; 23(3):242-8. PubMed ID: 20389243
[TBL] [Abstract][Full Text] [Related]
30. Intravenous immunoglobulin as first treatment in diabetics with concomitant distal symmetric axonal polyneuropathy and CIDP.
Cocito D; Ciaramitaro P; Isoardo G; Barbero P; Migliaretti G; Pipieri A; Proto G; Quadri R; Bergamasco B; Durelli L
J Neurol; 2002 Jun; 249(6):719-22. PubMed ID: 12111305
[TBL] [Abstract][Full Text] [Related]
31. Short-term and long-term effects of immunoadsorption in refractory chronic inflammatory demyelinating polyneuropathy: a prospective study in 17 patients.
Dorst J; Ludolph AC; Senel M; Tumani H
J Neurol; 2018 Dec; 265(12):2906-2915. PubMed ID: 30293110
[TBL] [Abstract][Full Text] [Related]
32. Chronic inflammatory demyelinating polyradiculoneuropathy in diabetic patients.
Haq RU; Pendlebury WW; Fries TJ; Tandan R
Muscle Nerve; 2003 Apr; 27(4):465-70. PubMed ID: 12661048
[TBL] [Abstract][Full Text] [Related]
33. Long-term efficacy of interferon-alpha in chronic inflammatory demyelinating polyneuropathy.
Pavesi G; Cattaneo L; Marbini A; Gemignani F; Mancia D
J Neurol; 2002 Jun; 249(6):777-9. PubMed ID: 12173577
[No Abstract] [Full Text] [Related]
34. Rituximab in a childhood-onset idiopathic refractory chronic inflammatory demyelinating polyneuropathy.
D'Amico A; Catteruccia M; De Benedetti F; Vivarelli M; Colucci M; Cascioli S; Bertini E
Eur J Paediatr Neurol; 2012 May; 16(3):301-3. PubMed ID: 21903431
[TBL] [Abstract][Full Text] [Related]
35. Diffusion tensor imaging can be used to detect lesions in peripheral nerves in patients with chronic inflammatory demyelinating polyneuropathy treated with subcutaneous immunoglobulin.
Markvardsen LH; Vaeggemose M; Ringgaard S; Andersen H
Neuroradiology; 2016 Aug; 58(8):745-52. PubMed ID: 27114080
[TBL] [Abstract][Full Text] [Related]
36. Severe Chronic Inflammatory Demyelinating Polyneuropathy Ameliorated following High-dose (3 g/kg) Intravenous Immunoglobulin Therapy.
Seino Y; Nakamura T; Hirohata M; Kawarabayashi T; Okushima T; Shoji M
Intern Med; 2019 Mar; 58(6):855-859. PubMed ID: 30449785
[TBL] [Abstract][Full Text] [Related]
37. Pulse cyclophosphamide therapy in chronic inflammatory demyelinating polyneuropathy.
Good JL; Chehrenama M; Mayer RF; Koski CL
Neurology; 1998 Dec; 51(6):1735-8. PubMed ID: 9855536
[TBL] [Abstract][Full Text] [Related]
38. Nerve excitability changes after intravenous immunoglobulin infusions in multifocal motor neuropathy and chronic inflammatory demyelinating neuropathy.
Boërio D; Créange A; Hogrel JY; Guéguen A; Bertrand D; Lefaucheur JP
J Neurol Sci; 2010 May; 292(1-2):63-71. PubMed ID: 20219211
[TBL] [Abstract][Full Text] [Related]
39. Rituximab in patients with chronic inflammatory demyelinating polyradiculoneuropathy: a report of 13 cases and review of the literature.
Benedetti L; Briani C; Franciotta D; Fazio R; Paolasso I; Comi C; Luigetti M; Sabatelli M; Giannini F; Mancardi GL; Schenone A; Nobile-Orazio E; Cocito D
J Neurol Neurosurg Psychiatry; 2011 Mar; 82(3):306-8. PubMed ID: 20639381
[TBL] [Abstract][Full Text] [Related]
40. A review of the use of biological agents for chronic inflammatory demyelinating polyradiculoneuropathy.
Stübgen JP
J Neurol Sci; 2013 Mar; 326(1-2):1-9. PubMed ID: 23337197
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
